CD4 and head and neck squamous cell carcinoma: According to the prognostic model of EC and head and neck squamous cell carcinoma (HNSCC) established by other researchers, tumors in high-risk patients were characterized by a higher proportion of CD4+ memory resting T lymphocytes [35, 36].